{"nct_id":"NCT00574288","title":"Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2008-03-26","start_date_type":"ACTUAL","primary_completion_date":"2015-01-09","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}